← Leaderboards
Pengyu Chen
Auburn University At Auburn
$4,181,329
Attributed
$5,473,092
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.1M · FY2019–25$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,473,092 · 2
By mechanism
R35$2,889,565 · 1
R01$2,583,527 · 1
Top collaborators
- Weiqiang Chen5 shared
Most similar at Auburn University At Auburn
Same institution · by research overlap
- Stewart W. Schneller$5,831,975
- Chris A. Kieslich$1,488,207
- Byron L Blagburn$76,451
- Katherine Michele Buckley$10,000
Others in their field
Other Emerging Leaders on “Cytokine”
- Thomas Denny · Duke University$22,999,550
- Valerie Fremont · Quality Biological, Inc.$19,261,930
- Stacey Lynn Clardy · Utah State Higher Education System--University Of Utah$15,093,619
- Amitinder Kaur · Tulane University Of Louisiana$12,771,713
- Gary Fanger · Rise Therapeutics, Llc$12,156,047
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$9,841,960
Research focus
CytokineImmuneNanoplasmonicClinical ApplicationCell CommunicationCellsMalignant NeoplasmsBehaviorSensorSignal TransductionTechnologyBiosensing TechniquesBiosensorImmunityPatient ResponseMeasurementFingerprintComplexLabelImmunologicsVisualizationBaseImmune System DiseasesAutoimmune Diseases
Grant awards (13)
Machine Learning-Assisted Integrated Optofluidic Nanoplasmonic Biosensing for Precision Immune Profiling and Monitoring$382,203
R35 · FY2025 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$493,522
R01 · FY2024 · CA
Machine Learning-Assisted Integrated Optofluidic Nanoplasmonic Biosensing for Precision Immune Profiling and Monitoring$379,956
R35 · FY2024 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$510,476
R01 · FY2023 · CA
Optofluidic Nanoplasmonic Biosensors for Next Generation Point-of-Care Immunoassays$375,542
R35 · FY2023 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$511,811
R01 · FY2022 · CA
Optofluidic Nanoplasmonic Biosensors for Next Generation Point-of-Care Immunoassays$375,542
R35 · FY2022 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$523,587
R01 · FY2021 · CA
Optofluidic Nanoplasmonic Biosensors for Next Generation Point-of-Care Immunoassays$375,542
R35 · FY2021 · GM · contact PI
Purchase of a modularized confocal microscope$249,696
R35 · FY2021 · GM · contact PI
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy$544,131
R01 · FY2020 · CA
Optofluidic Nanoplasmonic Biosensors for Next Generation Point-of-Care Immunoassays$375,542
R35 · FY2020 · GM · contact PI
Optofluidic Nanoplasmonic Biosensors for Next Generation Point-of-Care Immunoassays$375,542
R35 · FY2019 · GM · contact PI